Logo image
Evaluation of the NCCLS M44-P disk diffusion method for determining susceptibilities of 276 clinical isolates of Cryptococcus neoformans to fluconazole
Journal article   Open access   Peer reviewed

Evaluation of the NCCLS M44-P disk diffusion method for determining susceptibilities of 276 clinical isolates of Cryptococcus neoformans to fluconazole

M A Pfaller, S A Messer, L Boyken, C Rice, S Tendolkar, R J Hollis and D J Diekema
Journal of clinical microbiology, Vol.42(1), pp.380-383
01/2004
DOI: 10.1128/JCM.42.1.380-383.2004
PMCID: PMC321716
PMID: 14715784
url
https://doi.org/10.1128/JCM.42.1.380-383.2004View
Published (Version of record) Open Access

Abstract

We evaluated the NCCLS M44-P fluconazole disk diffusion method in comparison with the NCCLS M27-A2 broth microdilution method for determining the susceptibility of 276 isolates of Cryptococcus neoformans. Disk diffusion testing was performed using Mueller-Hinton agar supplemented with 2% glucose and 0.5 microg of methylene blue/ml. Among the 276 isolates, 259 (93.8%) were susceptible, 16 (5.8%) were susceptible--dose dependent, and 1 (0.4%) was resistant to fluconazole as determined by the NCCLS broth microdilution method. The overall categorical agreement between the two methods was 86%, with 0% very major errors, 2% major errors, and 12% minor errors. The disk diffusion method using Mueller-Hinton agar supplemented with glucose and methylene blue appears to be a useful approach for determining the fluconazole susceptibility of C. neoformans.
Antifungal Agents - pharmacology Fluconazole - pharmacology Microbial Sensitivity Tests - standards Diffusion Microbial Sensitivity Tests - methods Cryptococcus neoformans - drug effects Quality Control

Details

Metrics

Logo image